ABSTRACT

European populations face increasing exposure to novel physical and chemical agents, some of which may be detrimental to human health. Among these agents, electromagnetic fields (EMFs) are one of the most widespread and ubiquitous, especially as many new technologies and applications based on high-frequency fields are being developed and commercialised. Research on the possible health and biological effects of EMFs is being carried out by many centres in Europe, North America, Japan and other countries. The extent and diversity of these research activities, encompassing many areas of medical and biological research, as well as the latest developments in physics and engineering, make it particularly difficult to provide relevant, authoritative and timely input for the development of scientifically sound policies that have an impact on public health. Furthermore, complexities inherent to the hazards, exposures and potential risks may result in misinterpretation of evidence resulting from research or inappropriate application of risk assessment information to conditions or situations outside of those specifically tested.